Concurrently, the cytokine profile shift—characterized by reduced IFN-γ, TNF-α, and IL-2, alongside elevated IL-4 and IL-10—suggests that LEF promotes an anti-inflammatory milieu, countering the Th1 axis that drives vitiligo (Figure 5). The gene discussed is TNF; the disease is vitiligo.